37.15 - 38.24
22.75 - 39.30
1.11M / 91.9K (Avg.)
12.71 | 2.99
Analyze analyst forecasts for the company and compare them with competitors.
219.67B
The estimated revenue has increased from the previous period.
100.23B
The estimated EBITDA has increased from the previous period.
8.99
The estimated EPS has decreased from the previous period.
1.80B
The estimated net income has decreased from the previous period.
53.27B
The estimated EBIT has increased from the previous period.
13.46B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
4.24B
Revenue has increased from the previous period.
552.46%
Revenue growth rate has increased from the previous period.
1.76B
EBITDA has increased from the previous period.
41.59%
EBITDA margin has decreased from the previous period.
1.03B
EBIT has increased from the previous period.
24.39%
EBIT margin has increased from the previous period.
728.80M
Depreciation has increased from the previous period.
17.80M
Total cash has increased from the previous period.
0.42%
Cash percentage has increased from the previous period.
334.60M
Receivables have increased from the previous period.
7.89%
Receivables percentage has decreased from the previous period.
43.30M
Inventories have increased from the previous period.
1.02%
Inventory percentage has increased from the previous period.
783.80M
Accounts payable has increased from the previous period.
18.49%
Payables percentage has increased from the previous period.
-1.03B
Capital expenditure has increased from the previous period.
-24.22%
CapEx percentage has decreased from the previous period.
13.86%
WACC has decreased from the previous period.
18.00%
Cost of equity is unchanged from the previous period.
7.81%
Cost of debt is unchanged from the previous period.
2.84
Beta is unchanged from the previous period.
199.90M
Diluted shares outstanding is unchanged from the previous period.
3.07B
Total debt is unchanged from the previous period.
6.21B
Total equity is unchanged from the previous period.
9.28B
Total capital is unchanged from the previous period.
33.09%
Debt weighting is unchanged from the previous period.
66.91%
Equity weighting is unchanged from the previous period.
725.84M
EBIAT has increased from the previous period.
865.22M
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-167.53B
Terminal value is unchanged from the previous period.
-110.77B
Enterprise value has decreased from the previous period.
3.09B
Net debt is unchanged from the previous period.
-113.86B
Equity value has decreased from the previous period.
-569.58
Equity value per share has decreased from the previous period.
